NCT06118489

Brief Summary

The bronchodilator effects of volatile anesthetics have been the subject of many clinical studies. It is known that all volatile anesthetics, especially halothane, have similar effects. Sevoflurane has been shown to reduce airway resistance more than halothane and isoflurane. Desflurane is difficult to use as an induction agent due to its harsh and extremely pungent odor and airway irritating effect. However, it has been shown that the risk of cough, respiratory arrest and laryngospasm is no different from sevoflurane when administered after intravenous induction. Although it irritates the airway, it is thought to have a bronchodilation effect as it stimulates the sympathetic system. In spinal surgeries, prone position is required to access the operating field. When the patient is placed in the prone position, pulmonary physiology are affected. In the prone position, V/Q mismatch decreases and arterial oxygenation increases. However, lung compliance decreases and the peak inspiratory pressure required to reach the required tidal volume increases. The main purpose of this study is the effect of volatile agents on lung mechanics and oxygenisation in the prone position.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 7, 2023

Completed
24 days until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

June 10, 2025

Status Verified

June 1, 2025

Enrollment Period

2 months

First QC Date

October 31, 2023

Last Update Submit

June 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • compliance

    pulmonary compliance before, during and after prone position

    2 hour

Study Arms (2)

sevoflurane

desflurane

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

ASA 1-2 patients between the ages of 18 and 65 who are scheduled for spinal surgery will be included in the study.

You may qualify if:

  • years old
  • ASA1-2
  • Patients planned to undergo spinal surgery

You may not qualify if:

  • Lung disease
  • BMI 35 and above
  • Smokers
  • Those under the age of 18 and over the age of 65
  • Hepatorenal disease
  • Reynaud's disease
  • Burger disease
  • Hypotensive patient
  • Neuromuscular disease
  • Those who have had thoracic surgery before
  • Those with bad Allen test results

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yadigar Yılmaz

Istanbul, 34230, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

October 31, 2023

First Posted

November 7, 2023

Study Start

December 1, 2023

Primary Completion

February 1, 2024

Study Completion

February 1, 2024

Last Updated

June 10, 2025

Record last verified: 2025-06

Locations